FHD-286 是 BRM/BRG1 ATPase 的抑制剂，可用于治疗 BAF 相关疾病如急性髓性白血病的研究。
产品描述
FHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.
Cas No.
2671128-05-3
储存和溶解度
DMSO:245 mg/mL (435.43 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
